ZEISS Professional Education

Jennifer Gould, OD, FAAO, MS, FAAO, Dipl ABO

Jennifer Gould Blackmore, OD, MS, FAAO, walks through her workflow for diagnosing and managing retinal disease. Read on for original videos, case studies, scans, and step-by-step interpretations.

Leanne M. Liddicoat, O.D.

Leanne Liddicoat, OD, FCOVD, walks through her workflow for diagnosing and managing myopia. Read on for original videos, case studies, scans, and step-by-step interpretations.

Jennifer Gould, OD, FAAO, MS, FAAO, Dipl ABO

Jennifer Gould-Blackmore, OD, MS, FAAO, shares her systemic approach to diagnosing and managing retinal disease including: - Systemic medications and conditions that may affect the retina - Risk factors for retinopathy in diabetic and macular degeneration patients - How to utilize OCT analysis to differentiate clinical findings - How to leverage data analytic tools to help your clinical decision making - When to treat yourself and when to refer

Carolyn E. Majcher, OD, FAAO, Sarah Gleason, OD, FAAO, Dipl. ABO, Deep U. Parikh, MD

This is a discussion from, "Ophthalmic Medical Education Summit 2022: Case Study #3 & #4 Routine to Extreme Cases in Retina".

Deep U. Parikh, MD, Sarah Gleason, OD, FAAO, Dipl. ABO, Carolyn E. Majcher, OD, FAAO

Educational case study focused on diabetic retinopathy and macular degeneration with panel discussion and Q&A.

Vin T. Dang, OD, FAAO

Vin Dang, OD, walks through his workflow for diagnosing and managing glaucoma with videos and case studies, featuring original scans and his step-by-step interpretations.

Vin T. Dang, OD, FAAO

Dr. Vin Dang shares clinical pearls for managing and treating glaucoma.

Leanne M. Liddicoat, O.D.

Dr. Leanne Liddicoat shares her clinical workflow for myopia management.

Caroline R. Baumal, MD

A discussion on OCT Angiography (OCT-A) Imaging in Proliferative Diabetic Retinopathy (PDR).

James Armitage, BOptom, CertOcTher (ACO), MOptom, PhD, FAAO, FACO

As optometrists we are often the health practitioners that see our patients regularly and are responsible for the detection, diagnosis and, depending on jurisdiction, management of glaucoma. Ideally, we want to detect and manage as early as possible in the disease process, prior to extensive nerve or field loss but this generates significant diagnostic uncertainty because glaucoma is usually a slow progressing disease and the early signs are subtle. In this space, OCT, OCT-A and the trend-based analysis of dense data cubes can provide us with the information required to inform our diagnostic decision making, improving patient outcomes.